Burçe Ergel, Ph.D., is a Principal Scientist at Merck, specializing in biologics analytical research and development. With over 11 years of post-Ph.D. experience, including more than 6 years in the pharmaceutical industry, Burçe has established early developability screening strategies for biologics and has led early-stage protein therapeutics programs. They have previously held roles at Massachusetts General Hospital, Bristol Myers Squibb, Weill Cornell Medical College, and have completed a Ph.D. at Columbia University in Biological Sciences. Burçe is recognized for their ability to effectively collaborate across interdisciplinary teams and supervise protein characterization scientists.
This person is not in the org chart
This person is not in any teams
This person is not in any offices